- Home
- SQNS vs CNTB Comparison
SQNS vs CNTB Comparison
Compare SQNS & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- CNTB
- Stock Information
- Founded
- SQNS 2003
- CNTB 2012
- Country
- SQNS France
- CNTB United States
- Employees
- SQNS N/A
- CNTB N/A
- Industry
- SQNS Semiconductors
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- CNTB Health Care
- Exchange
- SQNS Nasdaq
- CNTB Nasdaq
- Market Cap
- SQNS 70.9M
- CNTB 65.5M
- IPO Year
- SQNS 2011
- CNTB 2021
- Fundamental
- Price
- SQNS $2.68
- CNTB $0.99
- Analyst Decision
- SQNS Strong Buy
- CNTB Strong Buy
- Analyst Count
- SQNS 1
- CNTB 1
- Target Price
- SQNS $7.50
- CNTB $8.00
- AVG Volume (30 Days)
- SQNS 136.5K
- CNTB 27.1K
- Earning Date
- SQNS 11-05-2024
- CNTB 09-05-2024
- Dividend Yield
- SQNS N/A
- CNTB N/A
- EPS Growth
- SQNS N/A
- CNTB N/A
- EPS
- SQNS 1.65
- CNTB N/A
- Revenue
- SQNS $30,555,000.00
- CNTB $24,116,000.00
- Revenue This Year
- SQNS $10.14
- CNTB N/A
- Revenue Next Year
- SQNS $8.54
- CNTB $63.90
- P/E Ratio
- SQNS $1.61
- CNTB N/A
- Revenue Growth
- SQNS N/A
- CNTB N/A
- 52 Week Low
- SQNS $0.85
- CNTB $0.68
- 52 Week High
- SQNS $7.43
- CNTB $2.84
- Technical
- Relative Strength Index (RSI)
- SQNS 55.52
- CNTB 33.74
- Support Level
- SQNS $2.63
- CNTB $1.00
- Resistance Level
- SQNS $2.82
- CNTB $1.09
- Average True Range (ATR)
- SQNS 0.17
- CNTB 0.09
- MACD
- SQNS 0.02
- CNTB -0.02
- Stochastic Oscillator
- SQNS 61.64
- CNTB 4.85
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.